Clincosm LogoSign in Get a demo

Type2 Diabetes Mellitus

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type2 Diabetes, Cognitive Impairment, Mild Trial in Kaohsiung (cognitive stimulation, as usual care)

Completed
  • Type2 Diabetes Mellitus
  • Cognitive Impairment, Mild
  • cognitive stimulation
  • as usual care
  • Kaohsiung, Taiwan
    Yong-Kang Clinic
Jun 8, 2023

Type2 Diabetes Trial in Van (Training on web-based diabetic foot care based on the Health Belief Model)

Recruiting
  • Type2 Diabetes Mellitus
  • Training on web-based diabetic foot care based on the Health Belief Model
  • Van, Turkey
    Van Yüzüncü Yıl Universty
Dec 31, 2022

Online Exercise Community Among Individuals With Type 2 Diabetes

Completed
  • Type 2 Diabetes
  • +3 more
  • Online exercise and group meetings
  • Copenhagen, København N, Denmark
    Center for Physical Activity Research
Dec 29, 2022

Type2 Diabetes Trial in Nanjing (Polyethylene Glycol Losenatide)

Recruiting
  • Type2 Diabetes Mellitus
  • Polyethylene Glycol Losenatide
  • Nanjing, Jiangsu, China
    Jianhua Ma
Nov 3, 2022

Type2 Diabetes Trial in Jakarta (Vitamin D 5000 IU, Placebo)

Active, not recruiting
  • Type2 Diabetes Mellitus
  • Vitamin D 5000 IU
  • Placebo
  • Jakarta, DKI Jakarta, Indonesia
    Community Health Centers Kecamatan Mampang Prapatan
Oct 24, 2022

Health Behavior, Type2 Diabetes Trial (AI health assistant)

Not yet recruiting
  • Health Behavior
  • Type2 Diabetes Mellitus
  • AI health assistant
  • (no location specified)
Sep 12, 2022

Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)

Completed
  • Type2 Diabetes Mellitus
  • Herlev, Denmark
    Herlev og Gentofte Hospital
Aug 17, 2022

Type2 Diabetes Trial in Athens (1.5 protein, 0.8 protein)

Recruiting
  • Type2 Diabetes Mellitus
  • 1.5 protein
  • 0.8 protein
  • Athens, Attiki, Greece
    National and Kapodistrian University of Athens
Jul 8, 2022

Diabetes and Its Complications Among US Latinos

Completed
  • Type2 Diabetes Mellitus
  • Cardiovascular Diseases
    • Santa Barbara, California
      Sansum Diabetes Research Institute
    Jun 2, 2022

    Molecules Associated With Progression of Prediabetes to Overt

    Recruiting
    • Type2 Diabetes Mellitus
    • Pre Diabetes
      • London, United Kingdom
        University of Roehampton
      May 17, 2022

      Type2 Diabetes Trial in Cairo (Natural Wellness Low-Glu low dose, Natural Wellness Low-Glu high dose, Metformin)

      Completed
      • Type2 Diabetes Mellitus
      • Natural Wellness Low-Glu low dose
      • +2 more
      • Cairo, Nasr City, Egypt
        Natural Welness Egypt
      Apr 27, 2022

      Type2 Diabetes, Osteopathy in Diseases Classified Elsewhere Trial in Central Islip, Old Westbury (OMT Protocol, OMT-Sham

      Recruiting
      • Type2 Diabetes Mellitus
      • Osteopathy in Diseases Classified Elsewhere
      • OMT Protocol
      • OMT-Sham Protocol
      • Central Islip, New York
      • +1 more
      Apr 25, 2022

      Format of Patient Education for Different Sociodemographic

      Recruiting
      • Type2 Diabetes Mellitus
      • Cardiovascular Diseases
      • Questionnaire
      • Leicester, United Kingdom
        Leicester Diabetes Centre
      Feb 25, 2022

      Type2 Diabetes Trial in Padang (Intervention group)

      Completed
      • Type2 Diabetes Mellitus
      • Intervention group
      • Padang, WEST Sumatera, Indonesia
        Ice Yolanda Puri
      Feb 15, 2022

      Cardiovascular Risk Factor, Type2 Diabetes, Insulin Sensitivity Trial in Davis (Naturally-sweetened orange juice,

      Recruiting
      • Cardiovascular Risk Factor
      • +3 more
      • Naturally-sweetened orange juice
      • Sugar-sweetened beverage
      • Davis, California
        University of California, Davis
      Jan 26, 2022

      Type2 Diabetes, Cardiovascular Diseases Trial in Chicago (Early Total Caloric Intake, Late Total Caloric Intake, Extended

      Recruiting
      • Type2 Diabetes Mellitus
      • Cardiovascular Diseases
      • Early Total Caloric Intake
      • +2 more
      • Chicago, Illinois
        University of Chicago
      Jan 27, 2022

      Type2 Diabetes, Metabolic Syndrome Trial in Ames (Glucola, Whole pea meal, Pea flour meal)

      Completed
      • Type2 Diabetes Mellitus
      • Metabolic Syndrome
      • Glucola
      • +4 more
      • Ames, Iowa
        Iowa State University, Food Science and Human Nutrition Departme
      Nov 23, 2021

      Type2 Diabetes Trial in Tuebingen, Duesseldorf (Empagliflozin (Jardiance®), Insulin Glargine (Lantus®))

      Active, not recruiting
      • Type2 Diabetes Mellitus
      • Empagliflozin (Jardiance®)
      • Insulin Glargine (Lantus®)
      • Tuebingen, Baden-Württemberg, Germany
      • +1 more
      Dec 2, 2021

      Type2 Diabetes, Coronary Heart Disease Trial in Portugal (Exposure to Anti-thrombotic treatment agents and glucose lowering

      Active, not recruiting
      • Type2 Diabetes Mellitus
      • Coronary Heart Disease
      • Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
      • Amadora, Lisbon, Portugal
      • +11 more
      Oct 26, 2021

      Non-Alcoholic Steatohepatitis (NASH), Type2 Diabetes Trial in Jerusalem (Oral Insulin)

      Completed
      Has Results
      • Non-Alcoholic Steatohepatitis (NASH)
      • Type2 Diabetes Mellitus
      • Oral Insulin
      • Jerusalem, Israel
        Hadassah Medical Center
      Aug 27, 2021

      Type2 Diabetes Trial in Chicago (Psyllium powder, Metformin Extended Release Oral Tablet)

      Completed
      • Type2 Diabetes Mellitus
      • Psyllium powder
      • Metformin Extended Release Oral Tablet
      • Chicago, Illinois
        Jesse Brown VA Medical Center
      Sep 1, 2021

      The Progress of Diabetes Mellitus After HMS5552 Treatment in

      Unknown status
      • Type2 Diabetes Mellitus
      • Nanjing, Jiangsu, China
        Nanjing First hospital
      Aug 25, 2021

      Type2 Diabetes Trial in Daytona Beach (Bexagliflozin, Digoxin)

      Completed
      Has Results
      • Type2 Diabetes Mellitus
      • Daytona Beach, Florida
        Covance CRU
      Jul 21, 2021

      Type2 Diabetes Trial in Evansville (Bexagliflozin, Metformin, Glimepiride)

      Completed
      Has Results
      • Type2 Diabetes Mellitus
      • Evansville, Indiana
        Clinical Research Site
      Jul 1, 2021

      Type2 Diabetes Trial in Japan, United States (Bexagliflozin tablets, 20 mg, Bexagliflozin tablets, )

      Completed
      Has Results
      • Type2 Diabetes Mellitus
      • Bexagliflozin tablets, 20 mg
      • Bexagliflozin tablets, placebo
      • Birmingham, Alabama
      • +42 more
      Jul 6, 2021